Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: in vivo murine model
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 28 (1) , 1376-1388
Abstract
The prognosis of patients with recurrent or metastatic head and neck squamous cell cancer (HNSCC) is generally poor. New treatments are required to supplement the current standard of care. Paclitaxel (PTX), an effective chemotherapeutic for HNSCC, has serious side effects. A polymeric nanocarrier system was developed for the delivery of PTX to improve HNSCC treatment. This study aimed to evaluate the antitumor efficacy of PTX-loaded polymeric nanoparticles based on α-TOS (PTX-NPs) administered by direct intratumoral injection into a Hypopharynx carcinoma squamous cells (FaDu) tumor xenograft mouse model. The nanocarrier system based on block copolymers of polyethylene glycol (PEG) and a methacrylic derivative of α-TOS was synthesized and PTX was loaded into the delivery system. Tumor volume was measured to evaluate the antitumor effect of the PTX-NPs. The relative mechanisms of apoptosis, cell proliferation, growth, angiogenesis, and oxidative and nitrosative stress were detected by Western blotting, fluorescent probes, and immunohistochemical analysis. The antitumor activity results showed that compared to free PTX, PTX-NPs exhibited much higher antitumor efficacy and apoptosis-inducing in a FaDu mouse xenograft model and demonstrated an improved safety profile. Ki-67, EGFR, and angiogenesis markers (Factor VIII, CD31, and CD34) expression were significantly lower in the PTX-NPs group compared with other groups (p < .05). Also, PTX-NPs induced oxidative and nitrosative stress in tumor tissue. Direct administration of PTX-loaded polymeric nanoparticles based on α-Tocopheryl Succinate at the tumor sites, proved to be promising for HNSCC therapy.Keywords
Funding Information
- Universidad Europea de Madrid (2016/UEM06, 2017/UEM21)
- Error! Hyperlink reference not valid.
- Biomateriales y Nanomedicina (CIBER-BBN) y la Fundación para la Excelencia y la Calidad en Oncología
This publication has 51 references indexed in Scilit:
- Effects of Paclitaxel on EGFR Endocytic Trafficking Revealed Using Quantum Dot Tracking in Single CellsPLOS ONE, 2012
- Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafersJournal of Controlled Release, 2012
- Nanoparticle PEGylation for Imaging and TherapyNanomedicine, 2011
- Antiangiogenic Activity of Sterically Stabilized Liposomes Containing Paclitaxel (SSL-PTX): In Vitro and In VivoAAPS PharmSciTech, 2010
- Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenograftsAnti-Cancer Drugs, 2007
- Reactive oxygen species in cancer cells: Live by the sword, die by the swordCancer Cell, 2006
- Induction of apoptosis by paclitaxel in human oral carcinoma cellsInternational Journal of Oral and Maxillofacial Surgery, 2006
- Taxane-Mediated Antiangiogenesis in Vitro Cancer Research, 2004
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- Differential Taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cells.Journal of Cell Biology, 1996